PATENT CLAIM ANALYSIS

Application Number: 16296012
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 14):
The method according to  claim 2 , wherein treatment with the combination of the RXR agonist and thyroid hormone reduces at least one symptom of Alzheimer's disease, wherein the at least one symptom reduced is difficulty with bodily movements, problems with coordination, slow bodily movement, daytime sleepiness, early awakening, nightmares, restless sleep, fatigue, dizziness, poor balance, restlessness, amnesia, confusion in the evening hours, dementia, difficulty thinking and understanding, impaired voice, soft speech, anxiety, apathy, leaking of urine, reduced facial expression, blank stare, constipation, or depression.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16118001', '15339762', '15812821', '15339752', '14507730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8567898107701148
- 35 USC 102 Novelty (BERT): 0.6934944537052102
- Combined Prediction Score: 0.8404602750636244
- Mean Citation Score: 701.6502839999997
- Max Citation Score: 781.9381
- Similarity Product: 682.3048925069094

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test